文献速递骨质疏松与代谢性骨病脊柱外科

系统性肥大细胞增多症患者椎体骨折患病率更高,而皮肤肥大细胞增多症与特发性肥大细胞活化综合征患者则不然

Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome.
PubMed 文献 · Osteoporos Int · 2019-03-07

该研究回顾性分析了2004至2015年在一家肥大细胞增多症专家中心诊断的89例系统性肥大细胞增多症(SM)、20例皮肤肥大细胞增多症(CM)和20例肥大细胞活化综合征(MCAS)患者,比较骨质疏松与脆性骨折特征。结果显示SM患者骨质疏松(44.9%)和骨折(28.1%)比例高于CM(15.0%、5.0%)和MCAS(10.0%、5.0%),SM患者椎体骨折(22.5%)多为多发,而非SM的肥大细胞疾病患者椎体骨折不常见(5%)。结论认为SM与多发椎体骨质疏松性骨折相关,而CM和MCAS似乎不与这一表型相关。

要点

  • SM患者骨质疏松比例44.9%,骨折比例28.1%,高于CM(15.0%、5.0%)和MCAS(10.0%、5.0%)。
  • SM患者椎体骨折患病率22.5%,且多为多发;非SM患者椎体骨折仅5%。
  • CM和MCAS患者椎体骨折不常见,且更常与骨质疏松危险因素相关。

核心结论

  • SM与多发椎体骨质疏松性骨折相关,而CM和MCAS似乎不与这一表型相关。

研究设计与样本

  • 回顾性分析2004至2015年在一家肥大细胞增多症专家中心连续诊断的所有SM、CM和MCAS患者的数据。
  • 共纳入89例SM患者、20例CM患者和20例MCAS患者,收集人口学、MCD临床体征、骨质疏松、骨折、骨密度及MCD生物学评估资料。
  • 将CM和MCAS患者与SM患者就骨质疏松和脆性骨折特征进行比较。

主要发现

  • 骨质疏松在CM(15.0%)和MCAS(10.0%)中较SM(44.9%)少见。
  • 骨折在非SM的肥大细胞疾病中较少见,CM为5.0%、MCAS为5.0%,而SM为28.1%。
  • SM患者椎体骨折患病率高(22.5%),且多为多发。
  • 非SM患者椎体骨折不常见(5%),且更常与骨质疏松危险因素相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Little is known about osteoporosis in mast cell disorders (MCDs) not related to systemic mastocytosis. We described osteoporosis and fractures in MCDs and showed that systemic mastocytosis was the only studied MCDs associated with osteoporotic vertebral fractures. INTRODUCTION: To describe osteoporosis (OP) and fragility fractures in mast cell disorders (MCDs). METHODS: We retrospectively analyzed data concerning all successive patients with systemic mastocytosis (SM), cutaneous mastocytosis (CM), and mast cell activation syndromes (MCAS) diagnosed in our mastocytosis expert center between 2004 and 2015. We collected data concerning demographic profiles, clinical signs of MCD, osteoporosis, fractures, densitometry, and biological assessment of MCD. We compared CM and MCAS patients with SM patients with regard to the characteristics of OP and fragility fractures. RESULTS: We assessed 89 SM patients, 20 CM patients, and 20 MCAS patients. Osteoporosis was less frequent in CM (15.0%) and MCAS (10.0%) than in SM (44.9%). Similarly, fractures were less frequent in non-SM MCDs, respectively 5.0%, 5.0%, and 28.1%. SM patients displayed high prevalence of vertebral fractures (22.5%), mostly multiple. Conversely, in non-SM patients, vertebral fractures appeared to be uncommon (5%) and more frequently associated with risk factors for osteoporosis. CONCLUSIONS: SM is associated with multiple vertebral osteoporotic fractures, whereas CM and MCAS do not appear to be associated with this phenotype.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Degboé Y, Eischen M, Apoil PA, et al. Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome. Osteoporos Int. 2019. PMID: 30847528. doi:10.1007/s00198-019-04918-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。